Innovative Clinical Research Launches in Clarksville to Expand Access to Clinical Trials

CLARKSVILLE, Tenn. - Oct. 27, 2025 - PRLog -- Innovative Clinical Research (ICR), a newly launched clinical research entity, is proud to announce its official opening in Clarksville, Tennessee. With a mission of "Improving lives through science," the company is dedicated to connecting patients with the latest advancements in medicine through clinical trials—right in their own community.

ICR partners with patients to offer access to new medications and diagnostics that are often only available at major academic medical centers. By bringing these opportunities to Clarksville, the company is helping to close the gap in healthcare access and empower individuals to take part in shaping the future of medicine.

Patients who participate in clinical studies through ICR do so at no cost. In many cases, all medical expenses are covered, and participants are compensated for their time and effort.

"We believe everyone deserves access to the most advanced medical care, no matter where they live," said Mary Kosinski PhD, Founder of ICR. "Our goal is to make sure patients in Clarksville have access to the same innovative treatments as those in larger cities, without having to travel."

The company's roots trace back more than eight years, during which its experienced team built a strong foundation in clinical research. Now, as an independent organization, ICR is poised to expand the scope of studies it undertakes and reach even more patients in the region.

Dr. Joseph Kosinski and Dr. Bradley Vander Veen, both well known primary care physicians, have a long-standing history of integrating clinical research into their medical practice. Through research, they've been able to bring medical advances directly to their patients and are now committed to helping other providers do the same. Their vision is to create a collaborative network where local physicians can offer cutting-edge treatments to their own patient populations—without the need to refer out to distant academic centers.

"Clinical research has allowed me to offer hope and new options to patients who had exhausted traditional treatments," said Dr. Vander Veen, Co-Founder of ICR. "It's incredibly rewarding to see how these studies can improve lives, and I'm excited to help other providers bring these opportunities to their patients as well."

ICR is actively enrolling patients and collaborating with physicians, sponsors, and key opinion leaders to advance clinical programs through the FDA process and bring new medical therapies to market. The team brings deep expertise across a range of therapeutic areas and is committed to maintaining the highest standards of regulatory compliance and patient care.

To Collaborate:
ICR welcomes partnerships with primary care providers, specialists, nurse practitioners and physician assistants seeking to help their patients access new medical therapies.  ICR focuses on fatty liver disease (MASLD/MASH), and cirrhosis and will provide free FibroScans to any patient referred to them.  ICR has many other studies including weight loss, high triglycerides, and other metabolic diseases.

For more information visit https://www.ICRresearch.com or contact information@ICRresearch.com | (931) 298-0336.